In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Avacta Group PLC

Latest From Avacta Group PLC

Asia Deal Watch: Takeda, Eisai Team With Non-Profit On Review Of Novel Targets For Antibiotics

The Japanese pharmaceutical companies will work with the Global Antibiotic Research and Development Partnership on screening targets for utility against WHO-listed priority pathogens. Avacta and LG Chem collaborate around the former’s Affimer technology.

Asia Pacific Deals

Avacta Affirms Alternative Antibody Potential With Upcoming Dx Deals

UK protein scaffold specialist Avacta expects to seal its first licensing deal in 2017 due to its order book for Affimer projects swelling 70% YOY. The AIM-listed group acquired the intellectual property for Affimer technology from Leeds University in 2012 and began commercialization in 2014.

Diagnostics ImmunoOncology

Execs On The Move, December 2016

Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

Leadership BioPharmaceutical

Avacta To Evaluate Affimers As Checkpoint Inhibitors, Anticoagulants

After raising $34 million from Britain’s stock market, the U.K. biotech now plans to develop its Affimer proteins as therapeutics as well as research reagents, to enable two complementary strands of business.

BioPharmaceutical United Kingdom
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
    • Large Molecule
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
  • Therapeutic Areas
  • Blood & Coagulation Disorders & Products
  • Cancer
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Avacta Group PLC
  • Senior Management
  • Alastair Smith, PhD, CEO
    Tim Sykes, CFO
  • Contact Info
  • Avacta Group PLC
    Phone: (44) (0) 844 414 0452
    Thorp Arch Estate
    Unit 651, St. 5
    Wetherby, LS23 7FZ